Are You Keeping Tabs on What Management Is Doing With Your Money?

Find out what you can do to keep yourself from staying up at night wondering about what companies like Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are doing with your hard-earned money.

| More on:

The idea behind making an investment in the equity of a publicly traded company is that you’re essentially handing over your hard-earned capital to the company’s managers, who you are expecting to earn you a fair return on your investment.

But how sure are you that’s what’s happening with the investments you currently own?

Understanding the shareholder-manager agency problem

The shareholder-manager agency problem is a problem that is about as old as capitalism itself.

The problem arises because the shareholders — that would be you as an investor, or the owner of a company — are the one providing the capital, or money, to pay the bills, hire staff, and invest in capital expenses like plants and equipment.

Yet it’s actually not you, but rather the employees, or management, of the company who are actually the ones responsible for making the hiring, firing and investment decisions on a day-to-day basis.

That means it’s up to the owners — and not the senior managers — of the company to ensure that management is making responsible decisions with the profits of the firm.

Let’s take a closer look at the options available to management as to what they are able to do with a firm’s capital and how those decisions can impact shareholder wealth.

Mergers and acquisitions

This is potentially the avenue most fraught with disastrous outcomes. That’s because sometimes managers of a company find themselves incentive to pursue merger and acquisition (M&A) opportunities to meet certain financial targets.

But the problem arises when those managers place undue emphasis on short-term financial incentives, like year-end bonuses, at the expense of more positive long-term shareholder outcomes.

That type of scenario can lead to disastrous investment outcomes. Look no further than the fate that befell Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) as but one recent example of an M&A strategy gone wrong.

Retiring debt obligations

Management can use a firm’s profits to retire outstanding debt obligations; sometimes it makes sense, and in other cases, not so much.

If, on the one hand, your firm (for example, the aforementioned Valeant Pharmaceuticals) has racked up an unsustainable balance of debt, paying down those financial obligations can be the responsible thing to do.

On the other hand, it may raise questions as to how management got themselves in that position in the first place.

In most cases, firms will target what is referred to as an optimal capital structure — or the optimal mix of debt in relation to assets and equity. Allocating capital in this manner can be an indication that management is, in fact, creating shareholder wealth by adding to or subtracting from its liabilities.

Returning profits to shareholders through dividends and buybacks

Paying a healthy and growing dividend has to be the most tried and true — and probably most “fail-safe” — approach to dealing with shareholders’ money in a responsible and sustainable manner.

Returning firm profits via either dividends or buybacks ensures that shareholders have a say on where the money will be directed — either through reinvestment in the firm or otherwise.

Bottom line

The best thing that investors can do for themselves to help mitigate the risk of the shareholder-manager agency problem is to only invest in companies with demonstrable track records of creating shareholder wealth.

Following that simple rule of thumb will help keep you from staying awake at night wondering what those strangers are doing with your money.

Stay Foolish.

Fool contributor Jason Phillips has no position in any of the stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Dividend Stocks

man in bowtie poses with abacus
Dividend Stocks

Here’s What Average 25-Year-Olds Have in a TFSA and RRSP Account

At 25, you don’t need a huge TFSA or RRSP balance to get ahead, you just need to start.

Read more »

ETFs can contain investments such as stocks
Dividend Stocks

Want Decades of Passive Income? Buy This Index Fund and Hold it Forever

This $3.5 billion exchange traded fund (ETF) paying monthly dividends is designed to be a "set-and-forget" cornerstone of your retirement.

Read more »

workers walk through an office building
Dividend Stocks

Down 60%, This Dividend Stock Is Worth a Closer Look

The ugly slide in Allied Properties REIT shares means its yield is about 8%, but the real bet is whether…

Read more »

iceberg hides hidden danger below surface
Dividend Stocks

The Canadian Blue-Chip Stock Trading at Bargain Prices Right Now

Telus (TSX:T) stock is starting to move lower again, but it is looking way too cheap as the yield swells…

Read more »

ETFs can contain investments such as stocks
Dividend Stocks

The Top 3 Canadian ETFs I’m Considering for 2026

Here's why these Canadian ETFs are the top picks I'm considering for income in 2026, especially amidst the growing volatility…

Read more »

Child measures his height on wall. He is growing taller.
Dividend Stocks

The $109,000 TFSA Milestone: How Do You Stack Up?

Most investors hit the $109,000 TFSA milestone with consistent contributions, not one big deposit.

Read more »

Dividend Stocks

3 Canadian Stocks to Buy for a “Pay Me First” Portfolio

A “pay me first” portfolio focuses on dividends that are supported by real cash flow, not headline yields.

Read more »

Bank of Canada Governor Tiff Macklem
Dividend Stocks

The Bank of Canada Speaks Up Again: Here’s What to Buy for a TFSA Now

With rates steady, a balanced TFSA can blend dependable income, a discounted yield opportunity, and long-run growth.

Read more »